Divis Laboratories Ltd (DIVISLAB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 509760, "name": "Divi's Lab.", "stock_name": "Divi's Lab.", "full_name": "Divis Laboratories Ltd", "name_url": "stocks-analysis/divi-s-lab", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "6,610.00", "chg": -100.85, "chgp": "-1.5%", "dir": -1, "prev_price": "6,710.85", "mcapval": "175,474.73 Cr", "mcap": "Large Cap", "scripcode": 532488, "symbol": "DIVISLAB", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE361B01024", "curr_date": "Jun 29, 01:45 PM", "curr_time": "13:46 PM", "last_traded_at": "Jun 29, 01:45 PM IST", "bse_nse_vol": "3.35 lacs", "exc_status": "Active", "traded_date": "Jun 29, 2026", "traded_date_str": "2026 06 29", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/divi-s-lab-509760-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "54,163 Put Contracts on Divis Laboratories Ltd at Rs 6,500 Strike Ahead of June Expiry", "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-heavy-put-option-activity-amid-bearish-sentiment-4076666", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/DivisLaboratori_most_active_stocks_puts_4076666.png", "date": "2026-06-29 10:00:10", "description": "Rs 6,500 put options on Divis Laboratories Ltd attracted 54,163 contracts on 29 Jun 2026, signalling significant activity just one day before the 30 June expiry. The stock trades at Rs 6,656.50, placing these puts approximately 2.3% out-of-the-money, which suggests a nuanced interpretation beyond outright bearishness." }, { "title": "Divis Laboratories Sees 0.45% Dip Amid Strong Technical Upgrade and Derivatives Surge", "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-045-dip-amid-strong-technical-upgrade-and-derivatives-surge-4075558", "imagepath": "", "date": "2026-06-27 17:03:56", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>22 Jun:</strong> Upgrade to Buy rating by MarketsMOJO</p>\n <p><strong>23 Jun:</strong> Stock price nears 52-week high at ₹6,784.95</p>\n <p><strong>25 Jun:</strong> Sharp 14.1% surge in open interest amid price decline</p>\n <p><strong>26 Jun:</strong> Week closes at ₹6,710.85 (-0.45%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.6,741.15</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.6,710.85</div><div class=\"stat-change n..." }, { "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Price Action", "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-mixed-price-action-4073563", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/DivisLaboratori_oi_spurts_by_underlying_4073563.png", "date": "2026-06-25 15:00:35", "description": "Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant 14.1% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite a modest price decline of 0.62% on 25 Jun 2026, the stock’s derivatives market reveals a complex interplay of directional bets and liquidity dynamics that merit close attention from investors and analysts alike." }, { "title": "Divis Laboratories Sees Significant Open Interest Surge Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-significant-open-interest-surge-amid-mixed-market-signals-4073440", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/DivisLaboratori_oi_spurts_by_underlying_4073440.png", "date": "2026-06-25 14:00:29", "description": "Divis Laboratories Ltd, a large-cap leader in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.8% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning despite a modest price decline and subdued volume patterns." }, { "title": "Divis Laboratories Ltd Upgraded to Buy on Strong Technical and Financial Performance", "link": "https://www.marketsmojo.com/news/stock-recommendation/divis-laboratories-ltd-upgraded-to-buy-on-strong-technical-and-financial-performance-4068328", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/DivisLaboratori_mojoScore_4068328.png", "date": "2026-06-23 08:17:20", "description": "Divis Laboratories Ltd has been upgraded from a Hold to a Buy rating, reflecting a marked improvement in its technical indicators, financial trends, valuation metrics, and overall quality. This upgrade, effective from 22 June 2026, is underpinned by robust quarterly results, bullish technical signals, and sustained long-term outperformance relative to benchmarks, signalling renewed investor confidence in the pharmaceutical giant." }, { "title": "Divis Laboratories Gains 1.63%: Mixed Signals Shape Weekly Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-gains-163-mixed-signals-shape-weekly-momentum-4065754", "imagepath": "", "date": "2026-06-20 17:04:22", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>15 Jun:</strong> Stock opens at Rs.6,608.15 amid Hold rating downgrade</p>\n <p><strong>16 Jun:</strong> Downgrade to Hold announced, mixed valuation and technical signals</p>\n <p><strong>17 Jun:</strong> Technical momentum shifts to bullish, stock rises 1.59%</p>\n <p><strong>19 Jun:</strong> Week closes at Rs.6,741.15, up 1.63% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.6,633.05</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div cla..." }, { "title": "Divis Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Mixed Indicators", "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-technical-momentum-shifts-signal-bullish-outlook-amid-mixed-indicators-4058096", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/DivisLaboratori_technicaldot_4058096.png", "date": "2026-06-17 08:02:39", "description": "Divis Laboratories Ltd has exhibited a notable shift in technical momentum, transitioning from a mildly bullish stance to a more assertive bullish trend. This change is underscored by a confluence of technical indicators including MACD, RSI, Bollinger Bands, and moving averages, signalling renewed investor confidence despite recent market headwinds." }, { "title": "Divis Laboratories Downgraded to Hold Amid Mixed Technical and Valuation Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/divis-laboratories-downgraded-to-hold-amid-mixed-technical-and-valuation-signals-4055333", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/DivisLaboratori_mojoScore_4055333.png", "date": "2026-06-16 08:18:21", "description": "Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 15 June 2026. This revision reflects a nuanced assessment across four key parameters: quality, valuation, financial trend, and technicals. While the company continues to demonstrate strong fundamentals and robust quarterly performance, evolving market dynamics and valuation concerns have tempered investor enthusiasm." }, { "title": "Divis Laboratories Gains 0.14%: 7 Key Factors Driving the Week’s Mixed Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-gains-014-7-key-factors-driving-the-weeks-mixed-momentum-4051467", "imagepath": "", "date": "2026-06-13 13:08:56", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>8 Jun:</strong> Sharp open interest surge amid price decline (Rs.6,516.35, -1.62%)</p>\n <p><strong>9 Jun:</strong> Intraday high of Rs.6,787.95 with 3.4% surge and heavy call/put option activity</p>\n <p><strong>10 Jun:</strong> Upgrade to Buy rating on strong technical and financial performance (Close Rs.6,756.40, +3.68%)</p>\n <p><strong>11 Jun:</strong> Technical momentum shifts amid mixed indicator signals (Close Rs.6,638.90, -1.74%)</p>\n <p><strong>12 Jun:</strong> Week closes at Rs.6,633.05 (-0.27%) with Sensex gaining 2.20%</p>\n </div>\n\n <div class=\"stats-row\">\n ..." } ], "total": 658, "sid": "509760", "stock_news_url": "https://www.marketsmojo.com/news/divis-laboratories-509760" }, "announcements": [ { "caption": "Information Regarding Deduction Of Income Tax At Source From Payment Of Dividend For The Financial Year 2025-26", "datetime": "11-Jun-2026", "details": "As per enclosed letter.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "04-Jun-2026", "details": "Copies of Newspaper Publication - Notice to the shareholders regarding transfer of unclaimed dividends and equity shares to IEPF", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript", "datetime": "29-May-2026", "details": "Submission of transcript of Earnings Conference Call held on May 23 2026", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Divis Laboratories Ltd has declared <strong>1500%</strong> dividend, ex-date: 24 Jul 26", "dt": "2026-07-24", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Divis Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 03 Aug 07", "dt": "2007-08-03", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Divis Laboratories Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 23 Sep 15", "dt": "2015-09-23", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

22 Jun: Upgrade to Buy rating by MarketsMOJO

23 Jun: Stock price nears 52-week high at ₹6,784.95

25 Jun: Sharp 14.1% surge in open interest amid price decline

26 Jun: Week closes at ₹6,710.85 (-0.45%)

Read full news article

Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Price Action

2026-06-25 15:00:35

Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant 14.1% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite a modest price decline of 0.62% on 25 Jun 2026, the stock’s derivatives market reveals a complex interplay of directional bets and liquidity dynamics that merit close attention from investors and analysts alike.

Read full news article

Divis Laboratories Sees Significant Open Interest Surge Amid Mixed Market Signals

2026-06-25 14:00:29

Divis Laboratories Ltd, a large-cap leader in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.8% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning despite a modest price decline and subdued volume patterns.

Read full news article

Divis Laboratories Ltd Upgraded to Buy on Strong Technical and Financial Performance

2026-06-23 08:17:20

Divis Laboratories Ltd has been upgraded from a Hold to a Buy rating, reflecting a marked improvement in its technical indicators, financial trends, valuation metrics, and overall quality. This upgrade, effective from 22 June 2026, is underpinned by robust quarterly results, bullish technical signals, and sustained long-term outperformance relative to benchmarks, signalling renewed investor confidence in the pharmaceutical giant.

Read full news article

Divis Laboratories Gains 1.63%: Mixed Signals Shape Weekly Momentum

2026-06-20 17:04:22

Key Events This Week

15 Jun: Stock opens at Rs.6,608.15 amid Hold rating downgrade

16 Jun: Downgrade to Hold announced, mixed valuation and technical signals

17 Jun: Technical momentum shifts to bullish, stock rises 1.59%

19 Jun: Week closes at Rs.6,741.15, up 1.63% for the week

Week Open

Rs.6,633.05

Week Close

Read full news article

Divis Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Mixed Indicators

2026-06-17 08:02:39

Divis Laboratories Ltd has exhibited a notable shift in technical momentum, transitioning from a mildly bullish stance to a more assertive bullish trend. This change is underscored by a confluence of technical indicators including MACD, RSI, Bollinger Bands, and moving averages, signalling renewed investor confidence despite recent market headwinds.

Read full news article

Divis Laboratories Downgraded to Hold Amid Mixed Technical and Valuation Signals

2026-06-16 08:18:21

Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 15 June 2026. This revision reflects a nuanced assessment across four key parameters: quality, valuation, financial trend, and technicals. While the company continues to demonstrate strong fundamentals and robust quarterly performance, evolving market dynamics and valuation concerns have tempered investor enthusiasm.